Skip to main content

Advertisement

Log in

Novel homozygous TSFM pathogenic variant associated with encephalocardiomyopathy with sensorineural hearing loss and peculiar neuroradiologic findings

  • Short Communication
  • Published:
neurogenetics Aims and scope Submit manuscript

Abstract

TSFM is a nuclear gene encoding the elongation factor Ts (EFTs), an essential component of mitochondrial translational machinery. Impaired mitochondrial translation is responsible for neurodegenerative disorders characterized by multiple respiratory chain complex defects, multisystemic involvement, and neuroradiological features of Leigh-like syndrome. With the use of a next-generation sequencing (NGS)–based multigene panel for mitochondrial disorders, we identified the novel TSFM homozygous variant c.547G>A (p.Gly183Ser) in a 5-year-old boy with infantile early onset encephalocardiomyopathy, sensorineural hearing loss, and peculiar partially reversible neuroimaging features. Our findings expand the phenotypic spectrum of TSFM-related encephalopathy, offering new insights into the natural history of brain involvement and suggesting that TSFM should be investigated in pediatric mitochondrial disorders with distinctive neurologic and cardiac involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M, Turnbull DM (2016) Mitochondrial diseases. Nat Rev Dis Primers 2:16080. https://doi.org/10.1038/nrdp.2016.80

    Article  PubMed  Google Scholar 

  2. Boczonadi V, Horvath R (2014) Mitochondria: impaired mitochondrial translation in human disease. Int J Biochem Cell Biol 48:77–84. https://doi.org/10.1016/j.biocel.2013.12.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ahola S, Isohanni P, Euro L, Brilhante V, Palotie A, Pihko H, Lönnqvist T, Lehtonen T, Laine J, Tyynismaa H, Suomalainen A (2014) Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy. Neurology 83(8):743–751. https://doi.org/10.1212/WNL.0000000000000716

    Article  PubMed  PubMed Central  Google Scholar 

  4. Morrison FS, Locke JM, Wood AR, Tuke M, Pasko D, Murray A, Frayling T, Harries LW (2013) The splice site variant rs11078928 may be associated with a genotype-dependent alteration in expression of GSDMB transcripts. BMC Genomics 14:627. https://doi.org/10.1186/1471-2164-14-627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lake NJ, Compton AG, Rahman S, Thorburn DR (2016) Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol 79(2):190–203. https://doi.org/10.1002/ana.24551

    Article  PubMed  Google Scholar 

  7. Jeppesen MG, Navratil T, Spremulli LL, Nyborg J (2005) Crystal structure of the bovine mitochondrial elongation factor Tu.Ts complex. J Biol Chem 280:5071–5081

    Article  CAS  PubMed  Google Scholar 

  8. Smeitink JA, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P, Sasarman F, Vriend G, Jacob-Hirsch J, Shaag A, Rechavi G, Welling B, Horst J, Rodenburg RJ, van den Heuvel B, Shoubridge EA (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrialtranslation elongation factor EFTs. Am J Hum Genet 79(5):869–877

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Emperador S, Bayona-Bafaluy MP, Fernández-Marmiesse A, Pineda M, Felgueroso B, López-Gallardo E, Artuch R, Roca I, Ruiz-Pesini E, Couce ML, Montoya J (2016) Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and non obstructive cardiomyopathy. Eur J Hum Genet 25(1):153–156. https://doi.org/10.1038/ejhg.2016.124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Traschütz A, Hayer SN, Bender B, Schöls L, Biskup S, Synofzik M (2018) TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids. Parkinsonism Relat Disord 60:176–178. https://doi.org/10.1016/j.parkreldis.2018.09.031

    Article  PubMed  Google Scholar 

  11. Vedrenne V, Galmiche L, Chretien D, de Lonlay P, Munnich A, Rötig A (2012) Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failure. J Hepatol 56(1):294–297. https://doi.org/10.1016/j.jhep.2011.06.014

    Article  CAS  PubMed  Google Scholar 

  12. Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, Laskowski A, Garone C, Liu S, Jaffe DB, Christodoulou J, Fletcher JM, Bruno DL, Goldblatt J, Dimauro S, Thorburn DR, Mootha VK (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 4(118):118ra10. https://doi.org/10.1126/scitranslmed.3003310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Giribaldi G, Doria-Lamba L, Biancheri R, Severino M, Rossi A, Santorelli FM, Schiaffino C, Caruso U, Piemonte F, Bruno C (2012) Intermittent-relapsing pyruvate dehydrogenasecomplexdeficiency: a case with clinical, biochemical, and neuroradiological reversibility. Dev Med Child Neurol 54(5):472–476. https://doi.org/10.1111/j.1469-8749.2011.04151.x

    Article  PubMed  Google Scholar 

  14. Sasai H, Shimozawa N, Asano T, Kawamoto N, Yamamoto T, Kimura T, Kawamoto M, Matsui E, Fukao T (2015) Successive MRI findings of reversible cerebral white matter lesions in patient with cystathionine β-synthase deficiency. Tohoku J Exp Med 237(4):323–327. https://doi.org/10.1620/tjem.237.323

    Article  CAS  PubMed  Google Scholar 

  15. Kozić DB, Petrović I, Svetel M, Pekmezović T, Ragaji A, Kostić VS (2014) Reversible lesions in the brain parenchyma in Wilson’s disease confirmed by magneticresonance imaging: earlier administration of chelating therapy can reduce the damage to the brain. Neural Regen Res 9(21):1912–1916. https://doi.org/10.4103/1673-5374.145360

    Article  PubMed  PubMed Central  Google Scholar 

  16. El-Hattab AW, Adesina AM, Jones J, Scaglia F (2015) MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 116(1–2):4–12. https://doi.org/10.1016/j.ymgme.2015.06.004

    Article  CAS  PubMed  Google Scholar 

  17. Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, Takiyama Y (2002) Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 59(6):816–824

    Article  CAS  PubMed  Google Scholar 

  18. Sakai S, Osaki M, Hidaka M, Kimura S, Ohya Y, Ago T, Kitazono T, Arakawa S (2018) Association between stroke-like episodes and neuronal hyperexcitability in MELAS with m.3243A>G: a case report. eNeurologicalSci. 12:39–41. https://doi.org/10.1016/j.ensci.2018.08.003 eCollection 2018 Sep.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chiara Fiorillo.

Ethics declarations

Tissue and blood samples were obtained for diagnostic purposes after ethical approval from the Ethic Committee of our Institution and written informed consent from the patient’s mother.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(JPG 79 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scala, M., Brigati, G., Fiorillo, C. et al. Novel homozygous TSFM pathogenic variant associated with encephalocardiomyopathy with sensorineural hearing loss and peculiar neuroradiologic findings. Neurogenetics 20, 165–172 (2019). https://doi.org/10.1007/s10048-019-00582-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-019-00582-5

Keywords

Navigation